Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery

Objective. To investigate the use of the risk-adjusted sequential probability ratio test in monitoring the cumulative occurrence of adverse clinical outcomes. Design. Retrospective analysis of three longitudinal datasets. Subjects. Patients aged 65 years and over under the care of Harold Shipman bet...

Full description

Saved in:
Bibliographic Details
Published inInternational journal for quality in health care Vol. 15; no. 1; pp. 7 - 13
Main Authors SPIEGELHALTER, DAVID, GRIGG, OLIVIA, KINSMAN, ROBIN, TREASURE, TOM
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.02.2003
OXFORD UNIVERSITY PRESS
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective. To investigate the use of the risk-adjusted sequential probability ratio test in monitoring the cumulative occurrence of adverse clinical outcomes. Design. Retrospective analysis of three longitudinal datasets. Subjects. Patients aged 65 years and over under the care of Harold Shipman between 1979 and 1997, patients under 1 year of age undergoing paediatric heart surgery in Bristol Royal Infirmary between 1984 and 1995, adult patients receiving cardiac surgery from a team of cardiac surgeons in London, UK. Main outcome measure. Annual and 30-day mortality rates. Results. Using reasonable boundaries, the procedure could have indicated an ‘alarm’ in Bristol after publication of the 1991 Cardiac Surgical Register, and in 1985 or 1997 for Harold Shipman depending on the data source and the comparator. The cardiac surgeons showed no significant deviation from expected performance. Conclusions. The risk-adjusted sequential probability test is simple to implement, can be applied in a variety of contexts, and might have been useful to detect specific instances of past divergent performance. The use of this and related techniques deserves further attention in the context of prospectively monitoring adverse clinical outcomes.
Bibliography:istex:9B46391111DCA677FCE84CAFD1970C0A73CFDCA9
ark:/67375/HXZ-PM3R2Z55-H
local:003
ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1353-4505
1464-3677
DOI:10.1093/intqhc/15.1.7